This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

TIDES Europe: Oligonucleotide and Peptide Therapeutics

SAVINGS DEADLINE EXPIRES IN:

  • 00
    Days
  • 00
    Hrs
  • 00
    Mins
  • 00
    Secs
12 - 14 Nov 2024
Hamburg Congress CentreHamburg, Germany

Thibaut Willemin
Bioassay Scientist at mRNA Center of Excellence | Sanofi
Speaker

Profile


I graduated with a Bachelor’s Degree in Biochemistry and Molecular Biology, followed by a Master’s Degree in Molecular Biology and Infectiology from the University of Lyon. During my studies, I developed a great interest in infectious diseases and novel vaccine technologies. I worked on mRNA vaccines in the Laboratory of Tissue Biology and Therapeutic Engineering (LBTI) in Lyon and had the chance to develop virology assays in Boehringer Ingelheim. After those experiences, my goal was to work on new vaccine platforms and the analytical methods to evaluate them. I joined Sanofi to work on mRNA vaccines in 2021, and since then focused on developing cell-based assays to evaluate mRNA vaccines in-vitro activity.

Agenda Sessions

  • mRNA Vaccines Potency Assays: Exploring Correlations and Gaps Between Methods

    08:55